June was a hot month for investments in Israeli companies
Eloxx Pharmaceuticals, focused on the discovery, development and commercialization of compounds for the treatment of genetic diseases such as cystic fibrosis and cystinosis, received $24 million from the Israeli-Chinese Catalyst…
